Neuroblastoma 4S: A heterogeneous disease with variable risk factors and treatment strategies

Cancer

Volumn 80, Issue 5, 1997, Pages 834-843

  Van Noesel, Max M ^a   Hählen, Karel ^a   Hakvoort Cammel, Friederike G A J ^a   Egeler, R Maarten ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Infants; Neoplasm; Neuroblastoma; Therapy

Indexed keywords

CYCLOPHOSPHAMIDE; VINCRISTINE;

CANCER STAGING; CHILDHOOD CANCER; FEMALE; HEPATOMEGALY; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; METASTASIS; NEUROBLASTOMA; NEWBORN; ONCOGENE C MYB; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY FAILURE; REVIEW; RISK FACTOR;

ABDOMINAL NEOPLASMS; AGE OF ONSET; BONE MARROW NEOPLASMS; FATAL OUTCOME; FEMALE; GENE AMPLIFICATION; GENES, MYC; HEPATOMEGALY; HUMANS; INFANT; INFANT, NEWBORN; LIVER NEOPLASMS; MALE; NEOPLASM STAGING; NEUROBLASTOMA; PROGNOSIS; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS;

EID: 1842416036     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970901)80:5<834::AID-CNCR2>3.0.CO;2-L     Document Type: Review

References (63)

1. Young JLJ, Ries LG, Silverberg E, Horm JW, Miller RW. Cancer incidence, survival and mortality for children younger than 15 years. Cancer 1986;58:598-602.
2. Breslow N, McCann B. Statistical estimation of prognosis for children with neuroblastoma. Cancer Res 1971;31:2098-103.
3. Coldman AJ, Fryer JH, Elwood JM, Sonley MJ. Neuroblastoma: influence of age at diagnosis, stage, tumor site, and sex on prognosis. Cancer 1980;46:1896-901.
4. Jereb B, Bretsky SS, Vogel R, Helson L. Age and prognosis in neuroblastoma: review of 112 patients younger than 2 years. Am J Pediatr Hematol Oncol 1984;6:233-43.
5. Evans AE, D'Angio GJ, Randolph JA. A proposed staging system for children with neuroblastoma. Children's Cancer Study Group. Cancer 1971;27:374-8.
6. De Bernardi B, Pianca C, Boni L, Brisigotti M, Carli M, Bagnulo S, et al. for the Italian Cooperative Group on Neuroblastoma. Disseminated neuroblastoma (stage IV and IV-S) in the first year of life. Outcome related to age and stage. Cancer 1992;70:1625-33.
7. Evans AE, Baum E, Chard R. Do infants with stage IV-S neuroblastoma need treatment? Arch Dis Child 1981;56:271-4.
8. Nickerson HJ, Nesbit ME, Grosfeld JL, Baehner RL, Sather H, Hammond D. Comparison of stage IV and IV-S neuroblastoma in the first year of life. Med Pediatr Oncol 1995; 13:261-8.
9. Evans AE, Chatten J, D'Angio GJ, Gerson JM, Robinson J, Schnaufer L. A review of 17 IV-S neuroblastoma patients at the Children's Hospital of Philadelphia. Cancer 1980;45:833-9.
10. Haas D, Ablin AR, Miller C, Zoger S, Matthay KK. Complete pathologic maturation and regression of stage IVS neuroblastoma without treatment. Cancer 1988;62:818-25.
11. Labreveux de Cervens C, Hartmann O, Valteau D, Brugieres L, De Cervens T, Kalifa C, et al. Syndrome de Pepper neonatal. A propos d'une serie de 22 cas. Arch Fr Pediatr 1990; 47:91-6.
12. Stokes SH, Thomas PRM, Perez CA, Vietti TJ. Stage IV-S neuroblastoma. Results with definitive therapy. Cancer 1984; 53:2083-6.
13. Wilson PCG, Coppes MJ, Solh H, Chan HSL, Jenkin D, Greenberg ML, et al. Neuroblastoma stage IV-S: a heterogeneous disease. Med Pediatr Oncol 1991;19:467-72.
14. Bourhis J, Dominici C, McDowell H, Raschella G, Wilson G, Castello MA, et al. N-myc genomic content and DNA ploidy in stage IV-S neuroblastoma. J Clin Oncol 1991;9:1371-5.
15. Cohn SL, Herst CV, Maurer HS, Rosen ST. N-myc amplification in an infant with stage IVS neuroblastoma. J Clin Oncol 1987;5:1441-4.
16. Garvin J, Bendit I, Nisen PD. N-myc oncogene expression and amplification in metastatic lesions of stage IV-s neuroblastoma. Cancer 1990;65:2572-5.
17. Hann HL, Evans AE, Cohen IJ, Leitmeyer JE. Biological differences between neuroblastoma IV-S and IV. Measurement of serum ferritin and E-rosette inhibition in 30 children. N Engl J Med 1981;305:425-9.
18. Ikeda H, Nagashima K, Suzuki N, Takahashi A, Kuroiwa M, Hirato J. Retrospective analysis of biological factors in a recurrent IV-S neuroblastoma with intermediate-grade malignancy. J Pediatr Surg 1995;30:866-9.
19. Kerbl R, Urban CE, Lackner H, Höfler G, Ambros IM, Ratschek M, et al. Connatal localized neuroblastoma: the case to delay treatment. Cancer 1996;77:1395-401.
20. Nakagawara A, Sasazuki T, Akiyama H, Kawakami K, Kuwano A, Yokoyama T, et al. N-myc oncogene and stage IV-S neuroblastoma. Preliminary observations on ten cases. Cancer 1990;65:1960-7.
21. Nguyen TQ, Fisher GB, Tabbarah SO, Greer KE, Cooper PH. Stage IV-S metastatic neuroblastoma presenting as skin nodules at birth. Int J Dermatol 1988;27:712-3.
22. Tonini GP, Verdona G, De Bernardi B, Sansone R, Massimo L, Cornaglia-Ferraris P. N-myc oncogene amplification in a patient with IV-S neuroblastoma. Am J Pediatr Hematol Oncol 1987;9:8-10.
23. Tsuchida Y, Yokomori K, Saito S, Kaku H, Bessho F. Stage IV-S neuroblastoma involving the liver and ectopic liver. Cancer 1984;53:1609-11.
24. Brodeur GM, Pritchard J, Berthold F, Carlson NLT, Castel V, Castleberry RP, et al. for the INSS/INRC. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993;11:1466-77.
25. Nitschke R, Smith EI, Shochat S, Altshuler G, Travers H, Shuster JJ, et al. Localized neuroblastoma treated by surgery: a Pediatric Oncology Group Study. J Clin Oncol 1988;6:1271-9.
26. Nitschke R, Smith EI, Altshuler G, Altmiller D, Shuster J, Green A, et al. Postoperative treatment of nonmetastatic visible residual neuroblastoma: a Pediatric Oncology Group Study. J Clin Oncol 1991;9:1181-8.
27. Castleberry RP, Kun L, Shuster JJ, Altshuler G, Smith EI, Nitschke R, et al. Radiotherapy improves the outlook for children older than one year with POG stage C neuroblastoma. J Clin Oncol 1991;9:789-93.
28. Brodeur GM, Seeger RC, Barrett A, Berthold F, Castleberry RP, D'Angio G, et al. International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma. J Clin Oncol 1990;8:935-6.
29. Matthay KK, Sather HN, Seeger RC, Haase GM, Hammond GD. Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy. J Clin Oncol 1989;7:236-44.
30. Strother D, Shuster JJ, McWilliams N, Nitschke R, Smith EI, Joshi VJ, et al. Results of Pediatric Oncology Group protocol 8104 for infants with stages D and DS neuroblastoma. Am J Pediatr Hematol Oncol 1995;17:254-9.
31. Paul SR, Tarbell NJ, Korf B, Kretschmar CS, Lavally B, Grier HE, et al. Long term survival in Stage IV neuroblastoma in infants. Cancer 1991;67:1493-7.
32. Finklestein JZ, Klemperer MR, Evans A, Bernstein I, Leikin S, McCreadie S, et al. Multiagent chemotherapy for children with metastatic neuroblastoma: a report from Children's Cancer Study Group. Med Pediatr Oncol 1979;6:179-88.
33. Shuster JJ, Land VJ, Nitschke R, Berry DH, Cushing B. Phase II study for four-drug chemotherapy for metastatic neuroblastoma: Pediatric Oncology Group Study. Cancer Treat Rep 1983;67:187-8.
34. Bernard JL, Hartmann O, Zucker JM, Philip T. Alternating Induction chemotherapy with cyclophosphamide-adriamycin-vincristine (CAD) and high dose cisplatin-etoposide (CVP) for children with metastatic neuroblastoma (NB) over 1 year of age. Preliminary results of the French Cooperative NB87 Protocol [abstract]. Med Pediatr Oncol 1990;18:385.
35. Pole J, Casper J, Elfenbein G, Gee A, Gross S, Janssen W, et al. High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: a Pediatric Oncology Group Study. J Clin Oncol 1991;9:152-8.
36. Seeger RC, Villablanca JG, Matthay KK, Harris R, Moss TJ, Feig SA, et al. Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma. Prog Clin Biol Res 1991;366:527-33.
37. Brodeur GM, Castleberry RP. Neuroblastoma. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 2nd edition. Philadelphia: J.B. Lippincott Company, 1993:739-67.
38. Shimada H, Stram DO, Chatten J, Joshi VV, Hachitanda Y, Brodeur GM, et al. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis. J Natl Cancer Inst 1995;87:1470-6.
39. Shimada H, Chatten J, Newton WA Jr., Sachs N, Hamoudi AB, Chiba T, et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 1984;73:405-16.
40. Evans AE, D'Angio GE, Propert K, Anderson J, Hahn H-WL. Prognostic factors in neuroblastoma. Cancer 1987;59:1853-9.
41. Joshi VJ, Cantor AB, Altshuler G, Larkinn E, Neill J, Shuster J, et al. Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas. A clinicopathologic study of 211 cases from the Pediatric Oncology Group. Cancer 1992;69:2197-211.
42. Berthold F, Trechow R, Utsch S, Ziechang J. Prognostic factors in metastatic neuroblastoma: a multivariate analysis of 182 cases. Am J Pediatr Hematol Oncol 1992;14:207-15.
43. Tsuchida Y, Honna T, Iwanaka T, Saeki M, Taguchi N, Kanedo T, et al. Serial determination of serum neuron-specific enolase in patients with neuroblastoma and other pediatric tumors. J Pediatr Surg 1987;22:419-24.
44. Bourhis J, De-Vathaire F, Wilson GD, Hartmann O, Terrier-Lacombe MJ, Boccon-Gibod L, et al. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma. Cancer Res 1991;51:33-6.
45. Look AT, Hayes FA, Nitschke R, McWilliams NB, Green AA. Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med 1984;311:231-5.
46. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984; 224:1121-4.
47. Caron HN, van Sluis P, van Hoeve M, de Kraker J, Bras J, Slater R, et al. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Nat Genet 1993;4:187-90.
48. Caron H, van Sluis P, de Kraker J, Bökkerink J, Egeler RM, Laureys G, et al. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med 1996;334:225-30.
49. Kaplan DR, Hempstead BL, Martin-Zanca D, Chao MV, Parada LF. The TRK proto-oncogene product: a signal transducing receptor for nerve growth factor. Science 1991;252:554-8.
50. Nakagawara A, Arima M, Azar CG, Scavarda NJ, Brodeur G. Reverse relationship between TRK expression and N-myc amplification in human neuroblastomas. Cancer Res 1992; 52:1364-8.
51. D'Angio GJ, Evans AE, Koop CE. Special pattern of wide-spread neuroblastoma with a favourable prognosis. Lancet 1971;708:1046-9.
52. Knudson AG, Meadows AT. Regression of neuroblastoma IV-S: a genetic hypothesis. N Engl J Med 1980;302:1254-6.
53. Frantz CN. Origin of neuroblastoma IV-S. N Engl J Med 1980; 303:820-1.
54. Tonini GP. Neuroblastoma: a multiple biological disease. Eur J Cancer 1993;29:802-4.
55. Ambros PF, Ambros IM, Strehl S, Bauer S, Luegmayr A, Kovar H, et al. Regression and progression in neuroblastoma. Does genetics predict tumor behaviour? Eur J Cancer 1995;31: 510-5.
56. Ambros IM, Zellner A, Roald B, Amann G, Ladenstein R, Printz D, et al. Role of ploidy, chromosome Ip, and Schwann cells in the maturation of neuroblastoma. N Engl J Med 1996;334:1505-11.
57. Pritchard J, Hickman JA. Why does stage 4S neuroblastoma regress spontaneously? Lancet 1994;344:869-70.
58. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985;313:1111-6.
59. Hachitanda Y, Hata JI. Stage IVS neuroblastoma: a clinical, histological, and biological analysis of 45 cases. Hum Pathol 1996;27:1135-8.
60. Stephenson SR, Cook BA, Mease AD, Ruymann FB. The prognostic significance of age and pattern of metastases in stage IV-S neuroblastoma. Cancer 1986;58:372-5.
61. Martinez DA, King DR, Ginn-Pease ME, Haase GM, Wiener ES. Resection of the primary tumor is appropriate for children with stage IV-S neuroblastoma: an analysis of 37 patients. J Pediatr Surg 1992;27:1016-21.
62. DeCou JM, Bowman LC, Rao BN, Santana VM, Furman WL, Luo X, et al. Infants with metastatic neuroblastoma have improved survival with resection of the primary tumor. J Pediatr Surg 1995;30:937-41.
63. Hsu LL, Evans AE, D'Angio GJ. Hepatomegaly in neuroblastoma stage 4S: criteria for treatment of the vulnerable neonate. Med Pediatr Oncol 1996;27:521-8.